Inj, tyruko, 1 mg
Products billed under this code include Tyruko.
Payment limit per 1 MG, by effective quarter, 2Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Tyruko.
Payment limit per 1 MG, by effective quarter, 2Q26 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Tyruko | Sandoz Inc. | 61314-0543-94 | 300 | $7,319.10 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $24.397 | −$0.097 | 1 MG | Inj, tyruko, 1 mg | v1, posted September 17, 2026 |
| 3Q26 | $24.494 | +$0.173 | 1 MG | Inj, tyruko, 1 mg | v1, posted September 15, 2026 |
| 2Q26 | $24.321 | – | 1 MG | Inj, tyruko, 1 mg | v1, posted September 15, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.